USFDA gives final approval for Empagliflozin tablets

It is said that the tablet is used to lower blood sugar levels in people with type-II diabetes.

71
USFDA Approval

Last Updated on August 7, 2022 by The Health Master

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Empagliflozin Tablets USP 10 mg and 25 mg, a company statement announced.

It is said that the tablet is used to lower blood sugar levels in people with type-II diabetes.

It is also used to reduce the risk of stroke, heart attack, or death in people with type-II diabetes, along with heart and blood vessel disease.

The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ.

USFDA gives final approval to market this anti-inflammatory skin cream

USFDA grants approval for generic Cyclosporine Soft Gel capsules

USFDA gives nod for Diclofenac Sodium Topical Gel

USFDA gives nod for generic birth control pills

USFDA gives nod for Belimumab to treat Paediatric Patients

USFDA gives nod for this generic high Blood Pressure drug

FDA Haryana busted a fake medicine factory

USFDA issues Form 483 for 6 observations to Jubilant Pharmova

USFDA gives final approval to market this anti-inflammatory skin cream

FDA Maharashtra seizes diagnostic kits being sold without license

9th edition of Indian Pharmacopoeia released: Details

Govt is set to ban Codeine-based Cough Syrups and formulations

NPPA extends timeline for trade margin capping of these 5 Medical Devices

Govt releases new National Standards for Blood Centres and Blood Transfusion

Drug prices: What is One-molecule, One-price policy ?

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner